Mini-review:_Guillain Barrè syndrome and myelitis associated with SARS-CoV-2 infection

Research output: Contribution to journalReview articlepeer-review


Despite a likely underestimation due to the many obstacles of the highly infectious, intensive care setting, increasing clinical reports about COVID-19 patients developing acute paralysis for polyradiculoneuritis or myelitis determine additional impact on the disease course and outcome. Different pathogenic mechanisms have been postulated basing on clinical, laboratory and neuroimaging features, and response to treatments. Here we provide an overview with insights built on the available reports. Besides direct viral pathogenicity, a crucial role seems to be represented by immune-mediated mechanisms, supporting and further characterizing the already hypothesized neurotropic potential of SARS-CoV-2 and implying specific treatments. Proper clinical and instrumental depiction of symptomatic cases, as well as screening for their early recognition is advocated.

Original languageEnglish
Pages (from-to)136040
JournalNeuroscience Letters
Publication statusE-pub ahead of print - Jun 9 2021


Dive into the research topics of 'Mini-review:_Guillain Barrè syndrome and myelitis associated with SARS-CoV-2 infection'. Together they form a unique fingerprint.

Cite this